SCHEMBL22423740

SCHEMBL22423740

CC(C)/C(=C/C=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.38
MAPT P10636 3/20 0.38
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
XBP1 P17861 1/20 0.38
ATM Q13315 1/20 0.38
HPGD P15428 4/20 0.37
PTGS1 P23219 2/20 0.37
CXCR1 P25024 2/20 0.37
CXCR2 P25025 2/20 0.37
PTGS2 P35354 2/20 0.37
CYP3A4 P08684 2/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
ELANE P08246 1/20 0.37
RECQL P46063 1/20 0.37
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9849946 0.84 ALDH1A1 (0.41) ALDH1A1MAPK1TDP1SMN1; SMN2MAPT
SCHEMBL20556813 0.75 SMN1; SMN2 (0.42) ALDH1A1MAPK1TDP1SMN1; SMN2MAPT
SCHEMBL29028319 0.74 SMN1; SMN2 (0.36) ALDH1A1MAPK1TDP1SMN1; SMN2MAPT
SCHEMBL4815873 0.74 SMN1; SMN2 (0.41) ALDH1A1MAPK1TDP1SMN1; SMN2MAPT
SCHEMBL27552212 0.73 ALDH1A1 (0.35) ALDH1A1MAPK1TDP1CES2CES1
SCHEMBL5960470 0.72 AKR1C1 (0.45) ALDH1A1MAPK1MAPTLMNANPSR1
SCHEMBL2835097 0.72 AKR1C1 (0.45) ALDH1A1MAPK1MAPTLMNANPSR1
SCHEMBL27278216 0.72 TDP1 (0.40) ALDH1A1MAPK1TDP1SMN1; SMN2MAPT
SCHEMBL1307988 0.71 ALDH1A1 (0.44) ALDH1A1MAPK1TDP1MAPTCYP3A4
SCHEMBL186779 0.71 ALDH1A1 (0.44) ALDH1A1MAPK1TDP1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof NATIONAL GUARD HEALTH AFFAIRS (SA) 2021-11-02 US disclosed
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF NATIONAL GUARD HEALTH AFFAIRS (SA) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161823-B2 Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof PDK1, PDHA1, PDHA2 ALDH1A1 7/4885MAPK1 1437/4885TDP1 2632/4885
US-20200290975-A1 ANTICANCER 1,3-DIOXANE-4,6-DIONE DERIVATIVES AND METHOD OF COMBINATORIAL SYNTHESIS THEREOF PDK1, PDHA1, PDHA2 ALDH1A1 7/4885MAPK1 1437/4885TDP1 2632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.